Skip to Content

B 417 (Mephobarbital 50 mg)

Pill imprint B 417 has been identified as Mephobarbital 50 mg.

Mephobarbital is used in the treatment of seizure prevention; sedation; epilepsy and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Mephobarbital 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Mephobarbital 50 mg B 417
Mephobarbital
Imprint:
B 417
Strength:
50 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Barbiturate anticonvulsants
Barbiturates
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Breckenridge Pharmaceutical Inc
National Drug Code (NDC):
51991-0417

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide